Cytek Biosciences Inc
NASDAQ:CTKB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Cytek Biosciences Inc
NASDAQ:CTKB
|
US |
|
K
|
Kernel Holding SA
WSE:KER
|
UA |
|
W
|
Warehouse Group Ltd
OTC:WHGPF
|
NZ |
|
Orexo AB
F:C5G
|
SE |
|
B
|
Boeing Co
SGO:BA
|
US |
|
L
|
Legend Oil and Gas Ltd
OTC:LOGL
|
US |
|
Samsung Electronics Co Ltd
KRX:005930
|
KR |
Wall St Price Targets
CTKB Price Targets Summary
Cytek Biosciences Inc
According to Wall Street analysts, the average 1-year price target for CTKB is 5.8 USD with a low forecast of 4.8 USD and a high forecast of 7.88 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is CTKB's stock price target?
Price Target
5.8
USD
According to Wall Street analysts, the average 1-year price target for CTKB is 5.8 USD with a low forecast of 4.8 USD and a high forecast of 7.88 USD.
What is the Revenue forecast for Cytek Biosciences Inc?
Projected CAGR
8%
Over the last 5 years, the compound annual growth rate for Revenue has been 17%. The projected CAGR for the next 3 years is 8%.
What is the Gross Profit forecast for Cytek Biosciences Inc?
Projected CAGR
10%
Over the last 5 years, the compound annual growth rate for Gross Profit has been 15%. The projected CAGR for the next 3 years is 10%.
